Guggenheim Capital’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-16,393
| Closed | -$1.31M | – | 2264 |
|
|
2021
Q1 | $1.31M | Buy |
16,393
+3,355
| +26% | +$262K | 0.01% | 1259 |
|
|
2020
Q4 | $1.03M | Sell |
13,038
-1,107
| -8% | -$64.9K | 0.01% | 1334 |
|
|
2020
Q3 | $622K | Sell |
14,145
-88
| -0.6% | -$4.34K | ﹤0.01% | 1375 |
|
|
2020
Q2 | $629K | Buy |
14,233
+5,823
| +69% | +$217K | ﹤0.01% | 1379 |
|
|
2020
Q1 | $302K | Buy |
8,410
+2,864
| +52% | +$163K | ﹤0.01% | 1532 |
|
|
2019
Q4 | $394K | Sell |
5,546
-17
| -0.3% | -$1.23K | ﹤0.01% | 1696 |
|
|
2019
Q3 | $417K | Buy |
5,563
+27
| +0.5% | +$2.29K | ﹤0.01% | 1703 |
|
|
2019
Q2 | $447K | Buy |
5,536
+1,646
| +42% | +$116K | ﹤0.01% | 1707 |
|
|
2019
Q1 | $260K | Buy |
+3,890
| New | +$295K | ﹤0.01% | 1964 |
|
|
2018
Q4 | – | Sell |
-10,454
| Closed | -$962K | – | 2436 |
|
|
2018
Q3 | $962K | Sell |
10,454
-3,517
| -25% | -$335K | 0.01% | 1627 |
|
|
2018
Q2 | $1.37M | Sell |
13,971
-49,351
| -78% | -$5.52M | 0.01% | 1463 |
|
|
2018
Q1 | $7.06M | Buy |
63,322
+44,397
| +235% | +$4.98M | 0.02% | 819 |
|
|
2017
Q4 | $1.95M | Sell |
18,925
-2,102
| -10% | -$209K | ﹤0.01% | 1690 |
|
|
2017
Q3 | $1.98M | Buy |
21,027
+919
| +5% | +$72.5K | ﹤0.01% | 1668 |
|
|
2017
Q2 | $1.57M | Sell |
20,108
-1,321
| -6% | -$99.2K | ﹤0.01% | 1799 |
|
|
2017
Q1 | $1.72M | Buy |
21,429
+643
| +3% | +$51.1K | ﹤0.01% | 1771 |
|
|
2016
Q4 | $1.64M | Sell |
20,786
-2,774
| -12% | -$216K | ﹤0.01% | 1828 |
|
|
2016
Q3 | $1.84M | Sell |
23,560
-2,902
| -11% | -$211K | 0.01% | 1680 |
|
|
2016
Q2 | $1.82M | Sell |
26,462
-991
| -4% | -$68.4K | 0.01% | 1624 |
|
|
2016
Q1 | $1.96M | Sell |
27,453
-6,467
| -19% | -$406K | 0.01% | 1586 |
|
|
2015
Q4 | $2.11M | Buy |
33,920
+6,444
| +23% | +$393K | 0.01% | 1578 |
|
|
2015
Q3 | $1.56M | Sell |
27,476
-1,542
| -5% | -$81.7K | ﹤0.01% | 1776 |
|
|
2015
Q2 | $1.56M | Buy |
29,018
+3,017
| +12% | +$147K | ﹤0.01% | 1952 |
|
|
2015
Q1 | $1.24M | Buy |
26,001
+3,730
| +17% | +$165K | ﹤0.01% | 2127 |
|
|
2014
Q4 | $963K | Sell |
22,271
-12,169
| -35% | -$497K | ﹤0.01% | 2230 |
|
|
2014
Q3 | $1.18M | Sell |
34,440
-2,592
| -7% | -$91.5K | ﹤0.01% | 2129 |
|
|
2014
Q2 | $1.36M | Sell |
37,032
-1,496
| -4% | -$50.8K | ﹤0.01% | 2092 |
|
|
2014
Q1 | $1.3M | Sell |
38,528
-12,070
| -24% | -$398K | ﹤0.01% | 2096 |
|
|
2013
Q4 | $1.72M | Buy |
50,598
+11,352
| +29% | +$393K | 0.01% | 1900 |
|
|
2013
Q3 | $1.25M | Buy |
39,246
+4,291
| +12% | +$114K | ﹤0.01% | 1968 |
|
|
2013
Q2 | $789K | Buy |
+34,955
| New | +$757K | ﹤0.01% | 2188 |
|
Guggenheim Capital's CMD Position: Q2 2021 in Review
Guggenheim Capital sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 16,393 shares — an estimated $1.31M sold.
Guggenheim Capital first reported a position in CMD in Q2 2013 and held it in 31 quarters. The position peaked at $7.06M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Guggenheim Capital reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Guggenheim Capital sold 16,393 Cantel Medical Corporation shares in Q2 2021, an estimated $1.31M.
- Guggenheim Capital first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 31 quarters.
- Guggenheim Capital's Cantel Medical Corporation position peaked at $7.06M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Guggenheim Capital's 13F filing for Q2 2021, filed 13 Aug 2021.